The California Technology Assessment Forum (CTAF) is a nationally-recognized independent appraisal committee. CTAF convenes three times each year at public meetings to review objective evidence reports and develop recommendations for how stakeholders can apply evidence to improve the quality and value of health care. 

CTAF directly engages clinicians, patients, and payers during public meetings to discuss implications of the evidence for clinical decision-making and coverage policies. Application of evidence takes shape through new medical policies, benefit designs, and patient and clinician tools to improve clinical care and patient outcomes. All members of the CTAF Panel must meet ICER’s criteria for Conflict of Interest.

Next CTAF Meeting

Main Review
March 17, 2023

CTAF

The CTAF’s 2023 public meeting on lecanemab:

 

Alzheimer’s Disease Meeting Agenda

California Technology Assessment Forum Members

Rena K. Fox, MD

CTAF Chair; University of California, San Francisco

Ralph G. Brindis, MD, MPH, MACC, FSCAI, FAHA

CTAF Vice Chair; University of California, San Francisco

Felicia Cohn, PhD

Kaiser Permanente

Robert Collyar

Patient Advocate

Sanket Dhruva, MD, MHS, FACC

UCSF School of Medicine

Kimberly Gregory, MD, MPH

Cedars-Sinai Medical Center

Paul Heidenreich, MD, MS

Stanford University

Jeffrey Hoch, PhD

University of California, Davis

Jeffrey Klingman, MD

The Permanente Medical Group

Annette Langer-Gould, MD, PhD

Southern California Permanente Medical Group, Kaiser Permanente

Sei Lee, MD

UCSF, Division of Geriatrics

Joy Melnikow, MD, MPH

University of California, Davis

Elizabeth J. Murphy, MD, DPhil

Kathryn A. Phillips, PhD

University of California, San Francisco

Ann Raldow, MD, MPH

University of California, Los Angeles

Rita F. Redberg, MD, MSc, FACC

University of California, San Francisco

Joanna Smith, LCSW, MPH, CHA

Healthcare Liaison, Inc.

Alexander Smith, MD, MPH

University of California, San Francisco

Anthony Sowry, BA

National Patient Advocate Foundation